会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • METHOD TO PRODUCE FRIED VEGETABLE PRODUCTS
    • 生产流行蔬菜产品的方法
    • US20130017294A1
    • 2013-01-17
    • US13511626
    • 2010-11-25
    • Hugo Streekstra
    • Hugo Streekstra
    • A23L1/015A23L1/217C12N9/82A23L1/01
    • A23B7/155A23L5/11A23L5/25A23L19/03A23L19/18A23V2002/00A23V2200/048
    • The invention relates to a method for the preparation of fried vegetable products. In particular, it relates to a method for the preparation of fried vegetable products which have been subjected to an asparagine-reducing enzyme. The method comprises reducing the amount of enzyme product formed on the surface of the enzyme-treated vegetable material due to the action of the asparagine-reducing enzyme. If the amount of enzyme product is reduced before frying, this will contribute to the colour and the quality of the frying oil and of products subsequently fried in the oil and, thus, will minimize the loss of quality of the frying oil. The invention also relates to use of an asparagine-reducing enzyme preparation for preserving the colour of the frying oil.
    • 本发明涉及一种油炸蔬菜制品的制备方法。 特别涉及制备已经进行了天冬酰胺还原酶的油炸蔬菜制品的制造方法。 该方法包括减少由于天冬酰胺还原酶的作用而在酶处理的植物材料的表面上形成的酶产物的量。 如果在油炸之前酶产物的量减少,这将有助于油炸油和随后在油中油炸的产品的颜色和质量,并且因此将使煎炸油的质量损失最小化。 本发明还涉及一种用于保存煎炸油的颜色的天冬酰胺还原酶制剂的用途。
    • 7. 发明申请
    • PUFA supplements
    • PUFA补品
    • US20070184090A1
    • 2007-08-09
    • US11711086
    • 2007-03-20
    • Isabel Van WaterschootHugo Streekstra
    • Isabel Van WaterschootHugo Streekstra
    • A61K31/202A61K47/00
    • A61K31/202A23K20/158A23L33/12A61K31/20A61K2300/00
    • Edible formulations, such as polyunsaturated fatty acids (PUFAs) such as pharmaceutical compositions or nutritional supplements, are disclosed comprising arachidonic acid (ARA). They are adapted to deliver from 150 mg to 1 g per day of ARA and may contain other PUFAs, for example docosahexaenoic acid (DHA). The DHA dosage is from 400 to 600 mg per day, and the ratio of ARA:DHA may be from 1:5 to 5:1. Pharmaceutical compositions comprising ARA and DHA at a ratio of ARA:DHA of 1:1 to 1:2 are also disclosed, as are foodstuffs comprising 0.1 to 5% ARA. Such formulations can be used to increase ARA levels in vivo, for example in pregnant women or for people who have diseases or conditions associated with low ARA levels.
    • 公开了食用制剂,例如多不饱和脂肪酸(PUFAs),例如药物组合物或营养补充剂,其包括花生四烯酸(ARA)。 它们适于每天从150mg递送至1g,并可含有其它PUFA,例如二十二碳六烯酸(DHA)。 DHA剂量为每天400至600mg,ARA:DHA的比例可以为1:5至5:1。 还公开了包含ARA:DHA比为1:1至1:2的ARA和DHA的药物组合物,以及包含0.1至5%ARA的食品。 这样的制剂可用于增加体内的ARA水平,例如在孕妇或具有低ARA水平相关疾病或病症的人群中。